Registreer u om meldingen in te stellen voor instrumenten, economische gebeurtenissen en artikelen van de auteurs die u volgt.
Gratis registreren Heeft u al een account? Inloggen
Noteringen
Alle soorten instrumenten
- Alle soorten instrumenten
- Indexen
- Aandelen
- ETF's
- Fondsen
- Grondst.
- Valuta's
- Crypto
- Obligaties
- Certificaten
Probeer een andere zoekopdracht
🧮 Kiest u aandelen nog steeds op de ouderwetse manier? Dan is het tijd om van de kracht van AI te profiteren! ✨
KORTING van 50% benutten
Pgim Jennison Health Sciences Fund- Class Z (PHSZX)
Toevoegen/Verwijderen van een Portfolio
Voeg toe aan Portfolio
49,57
-0,12
-0,24%
Type:
Fonds
Markt:
Verenigde Staten
Emittent:
Prudential Funds (PGIM Investments)
Activaklasse:
Aandeel
- Beoordeling Morningstar:
- Totale activa: 929,16M
Prudential Jennison Health Sciences Z
49,57
-0,12
-0,24%
- Overzicht
- Profiel
- Historische Data
- Participaties
PHSZX Overzicht
Op deze pagina vindt u een uitgebreid profiel van Pgim Jennison Health Sciences Fund- Class Z. Kom meer te weten over onder meer het senior management, de totale activa, de investeringsstrategie en de contactgegevens van PHSZX.
Contact Informatie
Adres
One Seaport Plaza
New York,NY 10292
United States
New York,NY 10292
United States
Telefoon
+1 8002251852
Topmanagers
| Naam | Titel | Sinds | Tot |
|---|---|---|---|
| Daniel Matviyenko | Managing Director | 2020 | now |
| Biografie | Dan Matviyenko is a portfolio manager for Jennison’s healthcare strategies. He is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2020, Dan was with Malleus Capital as founder, chief investment officer, and portfolio manager. Prior to that, he held various senior positions at Tudor Investment as partner and portfolio manager as well as at UBS O’Connor as an executive director and portfolio manager. Dan received a BS in finance from the University of Connecticut. | ||
| Debra Netschert | Managing Director | 2015 | now |
| Biografie | Debra Netschert is a portfolio manager for Jennison’s healthcare strategies. She is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2008, she was with Magnetar Capital as a senior analyst specializing in health care. Prior to that, she worked at Amaranth Advisors focusing on biopharmaceuticals and at Lazard Capital Markets covering biotechnology. Debra began her research career as an associate biotechnology analyst at UBS. She received a BS in health science and MS in physical therapy from Boston University. | ||
| David Chan | Portfolio Manager | 1999 | 2022 |
| Biografie | David Chan, CFA, is a Managing Director and a Health Sciences Equity Portfolio Manager and Research Analyst of Jennison. Mr. Chan joined Jennison Associates in May 1992. He was previously with the Boston Consulting Group, where he was a team leader and consultant on projects in a wide variety of industries, but with a special focus in the health care area. Mr. Chan has also worked in various positions in the film and television industry. He received a BA in biochemistry from Harvard University and an MBA from Columbia University. | ||
| Michael A. Del Balso | Director | 2000 | 2017 |
| Biografie | Michael Del Balso is a large cap growth portfolio manager. He joined Jennison in 1972 as a research analyst. He later served as the director of research and became a portfolio manager in 1999. Prior to Jennison, he was a portfolio manager and research analyst at White, Weld & Company. Michael received a BS in industrial administration from Yale University and an MBA from Columbia University Business School. | ||
| John Van Belle | Managing Director | 1999 | 2002 |
| Biografie | John Van Belle, PhD, is a Managing Director and Portfolio Manager for QMA working within the Quantitative Equity team. In this capacity, he manages global and non-US portfolios. Prior to joining QMA, John taught Economics and Finance at the University of Virginia and Rutgers Graduate School of Management and was a Vice President in Currency Management Consulting at both Bankers Trust and Citibank. Previously, he worked in the Research department of the Federal Reserve Bank of New York. He has published numerous articles in the fields of Economics and Finance. John earned a BS in Economics from St. Joseph's College and a PhD in Economics from the University of Virginia. | ||
| Kathleen A. McCarragher | Managing Director | 1999 | 2000 |
| Biografie | Kathleen McCarragher is the head of growth equity and a large cap growth equity portfolio manager. She is responsible for overseeing the investment process, strategy implementation, and risk management for Jennison's growth equity platform. Kathleen is also a member of the Jennison Management Team, ESG Investment Leadership Team, and Jennison Board of Directors. Before joining Jennison in 1998, she was a managing director and the director of large cap growth equities with Weiss, Peck & Greer. Prior to that, she was an investor with State Street Research & Management. Kathleen received a BBA, summa cum laude, in finance and economics from the University of Wisconsin-Eau Claire and an MBA from Harvard Business School. | ||
Laat weten wat u vindt van Pgim Jennison Health Sciences Fund- Class Z
Weet u zeker dat u deze grafiek wilt verwijderen?
Verwijderen Annuleren
Vervang de toegevoegde grafiek met een nieuwe grafiek?
Vervang Annuleren
Richtlijnen voor commentaar
Voeg Grafiek toe aan Commentaar
Blokkering bevestigen
Weet u zeker dat u %USER_NAME% wilt blokkeren?
Als u dit doet, kunnen u en %USER_NAME% geen publicaties meer van elkaar zien op Investing.com.
%USER_NAME% is toegevoegd aan uw lijst met geblokkeerde personen
Omdat u de blokkering van deze persoon net hebt opgeheven, moet u 48 uur wachten om hem/haar weer te kunnen blokkeren.
Rapporteer dit commentaar
Ik vind dit commentaar
Commentaar gemarkeerd
Bedankt!
Uw bericht is ter beoordeling verstuurd naar de moderatoren